We observed a marked decrease in B16 melanoma cell glucose uptake, GLUT1, and LDH expression upon treatment with increasing concentrations of LDHi (Figure 3, A–C, and Supplemental Figure 4A). The gene discussed is SLC2A1; the disease is melanoma.